Anxiolytic effect of Anshenfang in rats.
- Author:
Xue ZHANG
1
;
Shiying HUANG
;
Shen ZHANG
;
Xiufang DING
;
Baotian CHEN
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Anti-Anxiety Agents; pharmacology; Drugs, Chinese Herbal; pharmacology; Glutamic Acid; metabolism; Hippocampus; metabolism; Male; Rats; Rats, Wistar; Receptors, GABA; metabolism; Receptors, N-Methyl-D-Aspartate; metabolism; gamma-Aminobutyric Acid; metabolism
- From: Journal of Southern Medical University 2012;32(1):80-84
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo assess the anxiolytic effect of Anshenfang granules (ASF), a compound traditional Chinese medicinal preparation, on anxiety in rats and the mechanism of its actions.
METHODSMale Wistar rats with anxiety induced by chronic emotional stress were randomized to receive treatments with diazepam or ASF at high, medium or low doses. The behavioral changes of the rats were evaluated using plus-maze test, after which the rats in normal control group, model group, and medium AFS dose group were sacrificed to measure the hippocampal contents of glutamic acid and γ-aminobutyric acid (GABA) using high-performance liquid chromatography (HPLC); immunohistochemistry was employed to evaluate the expressions of GABAA receptor and N-methyl-D-aspartate receptor 1 (NMDAR1).
RESULTSPlus-maze test showed obvious anxiety behaviors in the model group, which were significantly meliorated by diazepam and ASF, especially at the medium dose. Hippocampal glutamate levels increased and GABA decreased significantly in the model group, and such changes were obviously attenuated, by comparable amplitudes, by treatments with diazepam and medium-dose ASF. The model group showed significantly diminished GABAA receptor-positive cells and increased NMDAR1-positive cells, which were improved by diazepam and ASF at the medium dose.
CONCLUSIONASF produces strong anxiolytic effect in rats by increasing the content of GABA in the brain, enhancing GABAA receptor expression, reducing glutamic acid content, and decreasing NMDAR1 expression.